economist semaglutide A new class of drugs for weight loss could end obesity Semaglutide from Bench to Bedside:

Burn off some extra energy, which can nudge the scale down

This preserves muscle while fat loss continues

Wilding JPH, Batterham RL, Calanna S, et al

Conclusion Clinical trial data from large, controlled studies demonstrate the efficacy and safety of GLP-1 agonists in terms of A1C reduction, beneficial effects on body weight, and a low risk for hypoglycemic events when used as monotherapy

However, it is important to inform your doctor if you notice any persistent or worsening GI disturbances such as severe abdominal pain, nausea, vomiting, diarrhea, and unexpected weight loss

Oral Medications: Semaglutide can slow down how quickly the stomach empties